SEC Form 4 · accession 0001493152-18-003652
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jim Delshad
Director
Period of report
Jan 1, 2018
Accepted (ET)
Mar 20, 2018 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock OptionF1 | $1.97 | Jan 1, 2018 | A | 26,109 | A | — | Jan 1, 2028 | Common Stock | 26,109 | 121,442 | D |
Explanation of responses
- F1Vests in four (4) equal quarterly installments over the one year period from the date of grant.